Regulatory Requirements for Pharma Export: Guide 2026

March 30, 2026 Regulatory & Compliance

Exporting pharmaceuticals requires navigating complex regulatory landscapes. Each importing country has its own requirements for product registration, documentation, and quality compliance. Understanding these requirements is crucial for successful pharma export.

Key Regulatory Authorities Worldwide

  • US: USFDA (United States Food & Drug Administration)
  • Europe: EMA (European Medicines Agency)
  • UK: MHRA (Medicines and Healthcare products Regulatory Agency)
  • Canada: Health Canada
  • Australia: TGA (Therapeutic Goods Administration)
  • Africa/Asia: Country-specific authorities (NAFDAC in Nigeria, CDSCO in India, etc.)

Essential Documents for Pharma Export

1. COPP (Certificate of Pharmaceutical Product)

Issued by the exporting country's regulatory authority. Required for product registration in importing country. Must be legalized/apostilled.

2. GMP Certificate

Proof of Good Manufacturing Practices compliance. WHO-GMP is widely accepted.

3. Free Sale Certificate

Confirms product is freely sold in the exporting country.

4. Product Dossier (CTD Format)

Common Technical Document containing:

  • Module 1: Administrative information
  • Module 2: Summaries
  • Module 3: Quality (manufacturing, controls)
  • Module 4: Non-clinical studies
  • Module 5: Clinical studies

5. Shipping Documents

  • Commercial Invoice
  • Packing List
  • Bill of Lading/Airway Bill
  • Certificate of Origin
  • Insurance Certificate

Product Registration Process

Step 1: Market Research

Identify target market requirements, drug price control regulations, and registration timelines.

Step 2: Appoint Local Representative

Many countries require a local entity for product registration.

Step 3: Dossier Preparation

Compile CTD dossier with all required data (stability, bioequivalence, etc.).

Step 4: Submission & Review

Submit dossier to regulatory authority. Review timelines vary (3-18 months).

Step 5: Approval & Import License

Upon approval, obtain import license to start commercial supply.

Region-Specific Requirements

Africa (Nigeria, Kenya, etc.)

  • WHO-GMP certification mandatory
  • COPP with apostille
  • Local representative required
  • Product samples for testing

Asia Pacific (Vietnam, Philippines)

  • GMP compliance proof
  • Free sale certificate
  • Local agent/partner
  • Price approval may be required

CIS Region (Russia, Kazakhstan)

  • EAEU registration
  • Local clinical studies may be needed
  • Russian GMP compliance

Common Regulatory Challenges

  • Lengthy approval timelines
  • Changing regulations
  • Language barriers (translations required)
  • High registration fees
  • Post-approval variations

Indus Pharma's Regulatory Support

We assist our export partners with:

  • COPP and GMP certificates
  • CTD dossier preparation
  • Regulatory consultation
  • Stability data provision
  • Local representative coordination

Need Regulatory Support for Pharma Export?

Indus Pharma provides complete regulatory documentation for Pharmaceutical Products export.